Trial Profile
Reintroduction of platinum-based therapy after treatment with trabectedin in patients with relapsed ovarian cancer resistant to platinum
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Feb 2018
Price :
$35
*
At a glance
- Drugs Trabectedin (Primary) ; Carboplatin; Dexamethasone
- Indications Ovarian cancer
- Focus Therapeutic Use
- 24 Feb 2018 Status changed from recruiting to completed.
- 02 Sep 2015 New trial record